Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
Trial details
- Registry ID
- NCT05712694
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Pegargiminase
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)NCT05712694 | Polaris Group | Phase 3 | Terminated | 2026-05-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |